What do systematic reviews say?

Human deoxyribonuclease vs placebo

Human deoxyribonuclease showed no clear difference in clinical failure Number of children with no significant improvement… compared with placebo (low certainty).

• Interventions for primary (intrinsic) tracheomalacia in children 2012 · Cochrane Headline outcomes only
  OR 1.38 [0.37, 5.14]
  1 study · 38 participants
  Low

Human deoxyribonuclease vs placebo

• Interventions for primary (intrinsic) tracheomalacia in children 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 38 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colon cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.79 [0.61, 1.02]
  3 studies · 47584 participants
  Very low

Intervention not reported

The intervention showed no clear difference in inpatient and 30 day mortality ‐ Rectal cancer (low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.79 [0.51, 1.22]
  1 study · 1903 participants
  Low

Intervention not reported

The intervention may leads to lower inpatient and 30 day mortality ‐ Colorectal cancer (low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.74 [0.6, 0.91]
  2 studies · 11973 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colorectal cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.98 [0.79, 1.2]
  3 studies · 77823 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colon cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.89 [0.78, 1.01]
  7 studies · 263071 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Rectal cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 1.07 [0.76, 1.5]
  5 studies · 14941 participants
  Very low

Intervention not reported

The intervention showed no clear difference in early neonatal death (0 to 6 days) (moderate certainty).

• Traditional birth attendant training for improving health behaviours and pregnancy outcomes 2012 · Cochrane Headline outcomes only
  RR 0.83 [0.68, 1.01]
  3 studies · 37494 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in neurological sequelae at day 28 (moderate certainty).

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  RR 1.23 [0.74, 2.03]
  1 study · 4857 participants
  Moderate

Intervention not reported

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 113 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 113 participants
  Moderate

CBT vs no treatment

• Interventions to facilitate return to work in adults with adjustment disorders 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 105 participants
  Low

Intervention not reported

The intervention showed no clear difference in mortality 30‐day (moderate certainty).

• N‐acetylcysteine for sepsis and systemic inflammatory response in adults 2012 · Cochrane Headline outcomes only
  RR 1.07 [0.8, 1.43]
  11 studies · 930 participants
  Moderate

Intervention not reported

• N‐acetylcysteine for sepsis and systemic inflammatory response in adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  19 studies · 1309 participants
  Moderate

Intervention not reported

• N‐acetylcysteine for sepsis and systemic inflammatory response in adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  9 studies · 423 participants
  Moderate

Intervention not reported

• Telemedicine for the support of parents of high‐risk newborn infants 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 56 participants
  Very low

Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution)

• Nutritional interventions for liver‐transplanted patients 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 31 participants
  Very low

Postoperative feeding via nasojejunal tube vs postoperative parenteral nutrition (PN)

• Nutritional interventions for liver‐transplanted patients 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Very low